Nanjing, China · Founded 2017 · Privately Held (backing)
Developer of biomedical drugs intended for the treatment of immune and oncologic diseases. Biosion is based in Nanjing, China and was founded in 2017. Its last reported valuation was $182 million in Dec 2020. It has raised $133 million.
Last reported valuation
$182.3M
Oct 2026
Priced at
—
Total raised
$132.7M
Last round
—
Cap table — not yet on record
Biosion's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biosion with a free account
·The complete investor list: 17 names
·Watch Biosion: the Monday email on marks, rounds and moves
